Abiopharma

🔍 Stewart Laura Lee (Director)

Company: Sound Financial Bancorp, Inc. (SFBC)

Report Date: 2026-06-30

Detailed Transactions and Holdings:

• Sold 900 shares of Common Stock at $42.6 per share (Direct)
  Date: 2026-06-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 9,000.00 | transaction_form_type: 4 | Footnotes: F4, F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-30 | Code: H | nature_of_ownership: By ESOP | shares_owned_after: 14,409.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-30 | Code: H | nature_of_ownership: By 401(k) | shares_owned_after: 18,906.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-30 | Code: H | shares_owned_after: 49,602.00
• Holds 250 shares of Stock Option (Right to Buy) at $33.5 per share (Derivative)
  Date: 2026-06-30 | Code: H | Expires: 2029-01-25 | shares_owned_after: 250.00 | Footnotes: F1
• Holds 120 shares of Stock Option (Right to Buy) at $36.26 per share (Derivative)
  Date: 2026-06-30 | Code: H | Expires: 2030-01-31 | shares_owned_after: 120.00 | Footnotes: F1
• Holds 300 shares of Stock Option (Right to Buy) at $32.46 per share (Derivative)
  Date: 2026-06-30 | Code: H | Expires: 2031-01-27 | shares_owned_after: 300.00 | Footnotes: F1
• Holds 1,800 shares of Stock Option (Right to Buy) at $40.13 per share (Derivative)
  Date: 2026-06-30 | Code: H | Expires: 2033-01-27 | shares_owned_after: 1,800.00 | Footnotes: F1
• Holds 259 shares of Stock Option (Right to Buy) at $39.89 per share (Derivative)
  Date: 2026-06-30 | Code: H | Expires: 2034-01-26 | shares_owned_after: 259.00 | Footnotes: F2

Footnotes:

• F1: Options are fully exercisable.
• F2: Options vest in three equal annual installments beginning on January 26, 2025.
• F3: On December 10, 2025, the reporting person contributed 10,800 shares of Sound Financial Bancorp, Inc. common stock to the Stewart Charitable Remainder Trust ("CRT") for estate planning purposes, resulting in a change in form of beneficial ownership from direct to indirect. The reporting person is the sole lifetime beneficiary of the CRT and retains the right to receive distributions in accordance with the terms of the trust. An independent third-party trustee serves as the trustee of the CRT and holds sole voting and dispositive power over the shares held by the trust.
• F4: These shares were sold by the trustee of the CRT, and not at the direction of the reporting person, pursuant to instructions contained in the trust agreement governing the CRT, in accordance with Rule 10b5-1(c) adopted on December 10, 2025. Following the reported transaction, the reporting person continues to hold a meaningful equity interest in the Company through remaining share ownership and outstanding equity awards.